Evidence map›Paper›PMID 28466409›Full record

ArticleHeart and vessels2017

Effects of pitavastatin on walking capacity and CD34

Kenshiro Arao, Takanori Yasu, Yasuhiro Endo, Toshikazu Funazaki, Yoshimi Ota, Kazunori Shimada, Eiichi Tokutake, Naoki Naito, Bonpei Takase, Minoru Wake and 6 more

Open access · hybridAbstract readComparative StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart and vessels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Statins and Peripheral Arterial Disease: A Narrative Review.Frontiers in cardiovascular medicine · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Kenshiro AraoFirst Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Takanori YasuDepartment of Cardiovascular Medicine and Nephrology, Dokkyo Medical University Nikko Medical Center, 632 Takatoku Nikko, Tochigi, 321-2593, Japan. tyasu@dokkyomed.ac.jp.
Yasuhiro EndoDivision of Cardiovascular Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Toshikazu FunazakiDivision of Cardiovascular Medicine, Saiseikai Kawaguchi General Hospital, Saitama, Japan.
Yoshimi OtaDivision of Cardiovascular Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Kazunori ShimadaDepartment of Cardiology, Juntendo University School of Medicine, Tokyo, Japan.
Eiichi TokutakeDivision of Cardiology, Tokutake Clinic, Saitama, Japan.
Naoki NaitoDivision of Cardiovascular Medicine, Saiseikai Kawaguchi General Hospital, Saitama, Japan.
Bonpei TakaseDivision of Cardiovascular Medicine, National Defense Medical College, Saitama, Japan.
Minoru WakeDepartment of Cardiovascular Medicine, Okinawa Chubu Hospital, Okinawa, Japan.
Nahoko IkedaFirst Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Yasuto HorieDepartment of Cardiology, Dokkyo Medical University Nikko Medical Center, Tochigi, Japan.
Hiroyuki SugimuraDepartment of Cardiology, Dokkyo Medical University Nikko Medical Center, Tochigi, Japan.
Shin-Ichi MomomuraFirst Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Masanobu KawakamiFirst Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Investigators of the Anti-Arteriosclerosis and Lipid Lowering with Pitavastatin Evaluation Study in Nippon (ALPEN)
Jichi Medical University · JPSaiseikai Fukuoka General Hospital · JPJuntendo University · JPDokkyo Medical University · JPOkinawa Prefectural Chubu Hospital · JPSaiseikai Ibaraki Hospital · JP

Funding

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan 17790496
6 · The paper itself

Abstract

This multi-center prospective non-randomized comparative study investigated the effects of pitavastatin in patients with peripheral artery disease (PAD) in terms of exercise tolerance capacities and peripheral CD34

Indexed as

WalkingAC133 AntigenAgedAged, 80 and overAnkle Brachial IndexAntigens, CD34Cell CountExercise ToleranceFemaleHumansJapanMaleMiddle AgedPeripheral Arterial DiseaseProspective StudiesQuinolinesAC133 AntigenAntigens, CD34pitavastatinQuinolinesCD34+/133+ cellsExercisePeripheral artery diseaseStatins

Identifiers

PMID28466409
PMCPMC5614906
OpenAlexW2611642725

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.